Buy or sell Ginkgo Bioworks stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Ginkgo Bioworks Stock

Custom Microbes Design

Founded

2008

Notable Investors

Y Combinator

Headquarters

Boston MA, US

Total Funding

$1.1B

About Ginkgo Bioworks Stock

Ginkgo Bioworks is a biotech company that designs custom microbes. The company creates custom microbes for three main areas: cultured ingredients, strain improvement, and enzymes. For cultured ingredients, Ginkgo Bioworks creates engineered yeasts to produce ingredients via fermentation for perfumes, foods, cosmetics, etc. For strain improvement, Ginkgo Bioworks engineers in-use organisms to improve efficiency and sustainability. For enzymes, Ginkgo Bioworks aims to discover "better" enzymes for various applications, such as cheesemaking and pharmaceuticals.

Ginkgo Bioworks' platform consists of its Foundries and Codebase. Foundries are Ginkgo Bioworks way to automate organism design and Codebase is Ginkgo Bioworks' library of cell, enzyme and genetic programs that help jumpstart new programs and discoveries.

Ginkgo Bioworks was founded in 2009. The company is based in Boston, Massachusetts.

Investors

Funding History

July 2015$53.2M
June 2016$98.9M
October 2017$294M
September 2019$627M

Management

Co-Founder & Chief Executive Officer

Jason Kelly

Co-Founder

Barry Canton

Co-Founder

Austin Che

Co-Founder

Tom Knight

Co-Founder

Reshma Shetty

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Ginkgo Bioworks or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo